Skip to main content
. 2022 Mar 14;10(3):442. doi: 10.3390/vaccines10030442

Table 1.

The data show the levels of cellular immunity, humoral immunity (antibodies), and the distribution of the age and the sex of study participants within the study groups.

Group 1
(N = 55)
Group 2
(N = 55)
Group 3
(N = 45)
Group 4
(N = 45)
Cellular immunity
(mIU/mL)
MD 932.0 866.0 2203.0 22.0
IQR 2514.0 1242.0 5556.0 78.5
Antibodies
(IU/mL)
MD 128.0 222.9 831.7 3.3
IQR 320.4 470.9 906.6 2.8
Age
(years)
MD 46.0 52.0 49.0 43.0
IQR 15.0 13.0 20.0 14.0
Sex, No. (%) M 58.2 52.7 48.9 42.2
F 41.8 47.3 51.1 57.8

MD—median; IQR—interquartile range; M—male; F—female.